Jilin Aodong Pharmaceutical Group: Announcement on the issuance results of the first issue of 2024 medium-term notes (science and technology innovation notes)
Aodong, Jilin: Written confirmation from the Supervisory Committee on the registration and issuance of medium-term notes
Aodong, Jilin: Announcement on Registration and Issuance of Medium-Term Notes
Aodong, Jilin: Announcement on Aodong\'s debt-for-resale results
Aodong, Jilin: Third indicative announcement on Aodong\'s debt-for-resale
Aodong, Jilin: Second indicative announcement on Aodong's debt-for-resale
Aodong, Jilin: First Prompt Announcement on Aodong's Debt Repayment
Aodong, Jilin: Announcement of Resolutions of the First Bondholders' Meeting in Aodong to Transfer Bonds in 2022
Aodong, Jilin: Notice on holding the first bond holders\' meeting in Aodong to convert bonds in 2022
Aodong, Jilin: 2021 Equity Distribution Implementation Notice
Aodong, Jilin: 2022 Interest Payment Announcement on Convertible Corporate Bonds
Aodong, Jilin: 2021 Interest Payment Announcement on Convertible Corporate Bonds
Aodong, Jilin: Announcement on the results of the resale of “Aodong Convertible Bonds”
Aodong, Jilin: Third Prompt Announcement on the Resale of “Aodong Convertible Bonds”
Aodong, Jilin: Second Prompt Announcement on the Resale of “Aodong Convertible Bonds”
Aodong, Jilin: 2018 Corporate Convertible Corporate Bonds 2020 Tracking Credit Rating Report
Aodong, Jilin: First Prompt Announcement on the Resale of “Aodong Convertible Bonds”
Aodong, Jilin: Notice on holding the first “Aodong Debt Transfer” bond holders' meeting in 2020
Aodong, Jilin: 2020 Interest Payment Announcement on Convertible Corporate Bonds
Aodong, Jilin: An indicative announcement on the controlling shareholder's holdings of the company's convertible debt
No Data